Scientific Industries Inc (SCND) shareholders
SCNDOTCLaboratory Analytical InstrumentsFiscal year ends December 31
$0.68+0.00 (0.00%)
Close on Oct 19, 2026Market cap $8.16MP/E –Yield –
Ownership
Who owns Scientific Industries's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
11 buys · 0 sales
Net bought $88.25K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bleichroeder LP Joint filing with Bleichroeder Holdings LLC (22.69%), Andrew Gundlach (22.69%) | 2,965,026 | 22.69% | 13D (active) amendment | Apr 18, 2025 |
| Andrew Gundlach Joint filing with Bleichroeder LP (21.19%), Bleichroeder Holdings LLC (21.19%) | 2,715,026 | 21.19% | 13D (active) amendment | Sep 30, 2025 |
| Veradace Capital Management LLC Joint filing with Veradace Partners L.P. (13.56%), John Conlin (13.56%) and 1 more | 1,452,717 | 13.56% | 13D (active) | Dec 19, 2023 |
| Lytton-Kambara Foundation Joint filing with Lytton Laurence W (9.99%) | 1,245,527 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
| North Run - Due North Partners, LP Joint filing with North Run Capital, LP (9.99%), North Run Advisors, LLC (9.99%) and 4 more | 1,189,632 | 9.99% | 13G (passive) amendment | Jun 30, 2025 |
| Todd B. Hammer Joint filing with North Run Capital, LP (9.99%), North Run Advisors, LLC (9.99%) and 4 more | 1,189,632 | 9.99% | 13G (passive) amendment | Sep 30, 2025 |
| Thomas A. Satterfield, Jr. | 1,138,055 | 9.90% | 13G (passive) amendment | Dec 31, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John A. Moore | Chairman of the Board, Director | 1,018,941 | 8.54% | Nov 5, 2026 |
| Helena R. Santos | President and CEO, Director | 258,288 | 2.17% | Apr 1, 2026 |
| Zachary Rovinsky | Chief Financial Officer | – | – | Mar 17, 2026 |
| John J. Nicols | Director | 90,778 | 0.76% | Mar 17, 2026 |
| Michael Blechman | Director | 47,186 | 0.40% | Mar 17, 2026 |
| LP Bleichroeder | 10% owner | 1,453,351 | 12.18% | Apr 22, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John A. Moore Chairman of the Board, Director | Nov 5, 2026 | Buy | +10,000 | $0.60 | $6.00K | 1,018,941 |
| John A. Moore Chairman of the Board, Director | Oct 31, 2026 | Buy | +7,100 | $0.60 | $4.26K | 1,008,941 |
| John A. Moore Chairman of the Board, Director | Oct 31, 2026 | Buy | +51,200 | $0.65 | $33.28K | 1,001,841 |
| John A. Moore Chairman of the Board, Director | Aug 20, 2026 | Buy | +5,000 | $0.76 | $3.80K | 950,641 |
| John A. Moore Chairman of the Board, Director | Aug 20, 2026 | Buy | +14,700 | $0.71 | $10.44K | 945,641 |
| John A. Moore Chairman of the Board, Director | Jun 2, 2026 | Buy | +4,000 | $0.71 | $2.84K | 930,871 |
| John A. Moore Chairman, Director | Mar 23, 2026 | Buy | +9,000 | $0.58 | $5.22K | 926,871 |
| John A. Moore Chairman of the Board, Director | Feb 19, 2026 | Buy | +1,000 | $0.65 | $650 | 917,871 |
| John A. Moore Chairman, Director | Dec 17, 2025 | Buy | +6,500 | $0.53 | $3.45K | 663,371 |
| John A. Moore Chairman, Director | Dec 17, 2025 | Buy | +11,700 | $0.54 | $6.32K | 656,871 |
| John A. Moore Chairman, Director | Dec 5, 2025 | Buy | +20,000 | $0.60 | $12.00K | 645,171 |
| John A. Moore Chairman of the Board, Director | Sep 17, 2025 | Buy | +5,800 | $0.70 | $4.06K | 467,089 |
| John A. Moore Director | Sep 16, 2025 | Buy | +9,599 | $0.64 | $6.14K | 461,289 |
| John J. Nicols Director | Aug 20, 2025 | Award | +15,000 | $1.00 | $15.00K | 90,778 |
| Michael Blechman Director | Aug 20, 2025 | Award | +10,000 | $1.00 | $10.00K | 47,186 |
| John A. Moore Director | Aug 20, 2025 | Award | +30,000 | $1.00 | $30.00K | 451,690 |
| Michael Blechman Director | Apr 18, 2025 | Buy | +10,000 | $1.00 | $10.00K | 10,000 |
| John A. Moore Chairman of the Board, Director | Apr 18, 2025 | Buy | +35,000 | $1.00 | $35.00K | 139,782 |
| John J. Nicols Director | Apr 18, 2025 | Buy | +15,000 | $1.00 | $15.00K | 30,000 |
| LP Bleichroeder 10% owner | Apr 18, 2025 | Buy | +250,000 | $1.00 | $250.00K | 1,453,351 |
| John A. Moore Chairman of the Board, Director | Oct 31, 2024 | Buy | +7,000 | $0.97 | $6.79K | 479,772 |
| John A. Moore Director | Jun 13, 2024 | Buy | +9,200 | $1.43 | $13.16K | 414,590 |
| John A. Moore Director | Jun 13, 2024 | Buy | +7,100 | $1.53 | $10.86K | 405,390 |
| Helena R. Santos CEO and President, Director | Jan 17, 2024 | Buy | +11 | $2.00 | $22 | 258,288 |
| John A. Moore Director | Dec 20, 2023 | Buy | +2,030 | $2.00 | $4.06K | 398,290 |
| Jurgen Walter Schumacher Director | Dec 20, 2023 | Award | +67,500 | $2.00 | $135.00K | 80,131 |
| Christopher T. Cox Director | Dec 19, 2023 | Buy | +79,245 | $2.00 | $158.49K | 301,245 |
| John A. Moore Director | Dec 19, 2023 | Buy | +20,400 | $2.00 | $40.80K | 394,230 |
| John J. Nicols Director | Dec 13, 2023 | Buy | +15,000 | $2.00 | $30.00K | 15,000 |
| John A. Moore Director | Dec 13, 2023 | Buy | +26,100 | $2.00 | $52.20K | 353,430 |
| Marcus Frampton 10% owner | Dec 13, 2023 | Buy | +27,530 | $2.00 | $55.06K | 135,683 |
| Helena R. Santos President, Director | Dec 13, 2023 | Award | +1,250 | $2.00 | $2.50K | 257,016 |
| LP Bleichroeder 10% owner | Dec 13, 2023 | Buy | +600,000 | $2.00 | $1.20M | 1,203,351 |
| Joseph G. Cremonese Director | Jun 9, 2022 | Sale | −4,000 | $5.18 | $20.72K | 116,062 |
| Joseph G. Cremonese Director | Jun 9, 2022 | Sale | −3,600 | $5.18 | $18.65K | 120,062 |
| Joseph G. Cremonese Director | Jun 6, 2022 | Sale | −400 | $5.10 | $2.04K | 123,662 |
| Joseph G. Cremonese Director | May 27, 2022 | Sale | −1,000 | $5.00 | $5.00K | 124,062 |
| Joseph G. Cremonese Director | May 26, 2022 | Sale | −1,000 | $5.00 | $5.00K | 125,062 |
| Joseph G. Cremonese Director | May 23, 2022 | Sale | −1,000 | $5.00 | $5.00K | 126,062 |
| Joseph G. Cremonese Director | May 23, 2022 | Sale | −1,000 | $5.00 | $5.00K | 127,062 |
| Joseph G. Cremonese Director | May 19, 2022 | Sale | −740 | $5.00 | $3.70K | 128,062 |
| Joseph G. Cremonese Director | Mar 16, 2022 | Sale | −2,840 | $6.05 | $17.18K | 128,802 |
| Marcus Frampton Director | Mar 2, 2022 | Buy | +7,000 | $5.50 | $38.50K | 17,313 |
| John A. Moore Chairman of the Board, Director | Mar 2, 2022 | Buy | +13,000 | $5.50 | $71.50K | 294,730 |
| Helena R. Santos President and CEO, Director | Mar 2, 2022 | Buy | +380 | $5.50 | $2.09K | 255,576 |
| LP Bleichroeder 10% owner | Mar 2, 2022 | Buy | +45,456 | $5.50 | $250.01K | 603,351 |
| Joseph G. Cremonese Director | Dec 14, 2021 | Sale | −2,770 | $6.50 | $18.01K | 131,642 |
| Marcus Frampton Director | Dec 3, 2021 | Sale | −1,900 | $5.60 | $10.64K | 59,810 |
| Marcus Frampton Director | Dec 3, 2021 | Buy | +800 | $5.71 | $4.57K | 10,313 |
| Marcus Frampton Director | Dec 2, 2021 | Sale | −2,000 | $5.46 | $10.92K | 61,710 |
| Marcus Frampton Director | Dec 2, 2021 | Buy | +1,000 | $5.68 | $5.68K | 9,513 |
| Marcus Frampton Director | Nov 24, 2021 | Buy | +378 | $5.77 | $2.18K | 8,513 |
| Marcus Frampton Director | Nov 23, 2021 | Sale | −1,050 | $5.64 | $5.92K | 63,710 |
| Marcus Frampton Director | Jun 29, 2021 | Buy | +500 | $10.73 | $5.37K | 8,135 |
| Marcus Frampton Director | Jun 28, 2021 | Sale | −3,100 | $10.58 | $32.80K | 64,760 |
| Roy T. Eddleman 10% owner | Apr 29, 2021 | Award | +421,052 | $4.75 | $2.00M | 1,232,888 |
| John A. Moore Chairman of the Board, Director | Apr 29, 2021 | Award | +21,052 | $4.75 | $100.00K | 271,204 |
| Helena R. Santos President and CEO, Director | Apr 29, 2021 | Buy | +1,052 | $4.75 | $5.00K | 254,670 |
| Robert Nichols Corporate Secretary | Apr 29, 2021 | Award | +2,104 | $4.75 | $9.99K | 29,189 |
| Marcus Frampton Director | Dec 14, 2020 | Buy | +1,755 | $8.15 | $14.30K | 7,635 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Sep 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-68.2%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Scientific Industries's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
See a number that looks wrong?